Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Philip M Bath; Iris Mhlanga; Lisa J Woodhouse; Fergus Doubal; Katherine Oatey; Alan A Montgomery; Joanna M Wardlaw

doi:10.1136/svn-2022-001816

Article metrics

This article has a correction. Please see:

Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850) - April 01, 2023

PDF

PDF +
Supplementary
Material

Original research

Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Online download statistics by month:

Online download statistics by month: September 2022 to August 2023

	Abstract	Full	Pdf
Sep 2022	336	323	76
Oct 2022	306	308	123
Nov 2022	177	171	85
Dec 2022	126	122	36
Jan 2023	64	59	33
Feb 2023	147	145	115
Mar 2023	168	160	60
Apr 2023	148	139	59
May 2023	206	201	119
Jun 2023	187	180	57
Jul 2023	124	115	63
Aug 2023	133	120	50
Total	2122	2043	876

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Online download statistics by month:

Online download statistics by month: September 2022 to August 2023

Read the full text or download the PDF:

Log in using your username and password